title: [Efficacy of the anti-edema drug L-lysine aescinat in stroke].
abstract: Forty-nine patients with ischemic hemispheric stroke admitted within 48 hours of stroke onset were studied. Twenty-nine patients (the main group) received L-lysine aescinat as an anti-edema drug. The efficacy was evaluated clinically and by EEG and autonomic testing. The rapid recovery of wakefulness and reduction in neurological deficit as well as the improvement of brain electrical activity and autonomic functions were observed. L-lysine aescinat can be recommended to control the syndrome of intracranial hypertension in stroke.
authors: B G
authors: BG
authors: Gafurov
mesh_terms: D000328:Adult; D000368:Aged; D001929:Brain Edema / Q000188:drug therapy* / Q000209:etiology*; D004928:Escin / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D005260:Female; D023261:Glasgow Outcome Scale; D006801:Humans; D019586:Intracranial Hypertension / Q000188:drug therapy; D008239:Lysine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D020521:Stroke / Q000150:complications*; D016896:Treatment Outcome
chemical_list: D004928:Escin; D008239:Lysine